<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MDM</journal-id>
<journal-id journal-id-type="hwp">spmdm</journal-id>
<journal-id journal-id-type="nlm-ta">Med Decis Making</journal-id>
<journal-title>Medical Decision Making</journal-title>
<issn pub-type="ppub">0272-989X</issn>
<issn pub-type="epub">1552-681X</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0272989X11426176</article-id>
<article-id pub-id-type="publisher-id">10.1177_0272989X11426176</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Web-Only Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Test Result–Based Sampling</article-title>
<subtitle>An Efficient Design for Estimating the Accuracy of Patient Safety Indicators</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Taffé</surname><given-names>Patrick</given-names></name>
<degrees>PhD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Halfon</surname><given-names>Patricia</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Ghali</surname><given-names>William A.</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Burnand</surname><given-names>Bernard</given-names></name>
<degrees>MD</degrees>
</contrib>
<contrib contrib-type="author">
<collab>for the International Methodology Consortium for Coded Health Information (IMECCHI)</collab>
</contrib>
</contrib-group>
<aff id="aff1-0272989X11426176">Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois, and University of Lausanne, Lausanne, Switzerland (PT, PH, BB)</aff>
<aff id="aff2-0272989X11426176">Center for Health and Policy Studies, Department of Community Health Sciences, and Department of Medicine, University of Calgary, Calgary, Alberta, Canada (WAG)</aff>
<author-notes>
<corresp id="corresp1-0272989X11426176">Patrick Taffé, PhD, Health Care Evaluation Unit, Institute of Social and Preventive Medicine (IUMSP), Bugnon 17, 1005 Lausanne, Switzerland; telephone: +41 (0) 21 314 72 56; e-mail: <email>Patrick.Taffe@chuv.ch</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2012</year>
</pub-date>
<volume>32</volume>
<issue>1</issue>
<fpage>E1</fpage>
<lpage>E12</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>11</month>
<year>2009</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>7</month>
<year>2011</year>
</date>
</history>
<abstract>
<p><bold>Objective</bold>. Accuracy studies of Patient Safety Indicators (PSIs) are critical but limited by the large samples required due to low occurrence of most events. We tested a sampling design based on test results (verification-biased sampling [VBS]) that minimizes the number of subjects to be verified. <bold>Methods</bold>. We considered 3 real PSIs, whose rates were calculated using 3 years of discharge data from a university hospital and a hypothetical screen of very rare events. Sample size estimates, based on the expected sensitivity and precision, were compared across 4 study designs: random and VBS, with and without constraints on the size of the population to be screened. <bold>Results</bold>. Over sensitivities ranging from 0.3 to 0.7 and PSI prevalence levels ranging from 0.02 to 0.2, the optimal VBS strategy makes it possible to reduce sample size by up to 60% in comparison with simple random sampling. For PSI prevalence levels below 1%, the minimal sample size required was still over 5000. <bold>Conclusions</bold>. Verification-biased sampling permits substantial savings in the required sample size for PSI validation studies. However, sample sizes still need to be very large for many of the rarer PSIs.</p>
</abstract>
<kwd-group>
<kwd>sensitivity and specificity</kwd>
<kwd>verification-biased sampling</kwd>
<kwd>sample size</kwd>
<kwd>health care quality indicator</kwd>
<kwd>hospital data</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January–February 2012</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In-hospital patient safety has been identified as a top priority internationally.<sup><xref ref-type="bibr" rid="bibr1-0272989X11426176">1</xref>–<xref ref-type="bibr" rid="bibr6-0272989X11426176">6</xref></sup> The Patient Safety Indicators (PSIs) developed by the United States Agency for Healthcare Research and Quality (AHRQ) are a set of 18 measures, based on routinely collected administrative data, designed to screen potentially avoidable complications of hospital care, for which high rates might indicate quality concerns.<sup><xref ref-type="bibr" rid="bibr7-0272989X11426176">7</xref></sup> The main concern with such indicators is their low sensitivity in flagging incidents. Although regularly used as quality indicators and to benchmark quality,<sup><xref ref-type="bibr" rid="bibr8-0272989X11426176">8</xref></sup> PSIs suffer from the shortcomings related to routinely collected administrative data (i.e., underreporting, inaccuracy and variability of diagnosis coding, and disputable preventability of the detected conditions).<sup><xref ref-type="bibr" rid="bibr9-0272989X11426176">9</xref>,<xref ref-type="bibr" rid="bibr10-0272989X11426176">10</xref></sup> On the other hand, the specificity of administrative data–based tools is generally considered high.</p>
<p>Even if PSIs have demonstrated minimal prerequisites for quality measures,<sup><xref ref-type="bibr" rid="bibr7-0272989X11426176">7</xref></sup> their widespread acceptance will only occur after additional testing of their diagnostic accuracy against a reference standard, usually the review of the medical record by one or, preferably, several experts.<sup><xref ref-type="bibr" rid="bibr11-0272989X11426176">11</xref></sup> Typically, these studies produce 4 measures, from a 2 × 2 contingency table relating test results (i.e., presence or absence of PSIs derived from administrative data) to the reference standard to permit the determination of sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV). Furthermore, the extent of statistical uncertainty (i.e., 95% confidence intervals [CIs]) around the estimates of these 4 parameters ideally should be reported. Despite the widespread use of PSIs in various settings, the 4 parameters discussed here are not well characterized for most PSIs.<sup><xref ref-type="bibr" rid="bibr12-0272989X11426176">12</xref>–<xref ref-type="bibr" rid="bibr15-0272989X11426176">15</xref></sup></p>
<p>In large screened populations, the simplest sampling design to assess diagnostic accuracy (in terms of sensitivity and specificity and the desired width of their associated 95% CI) is to verify a simple random sample drawn from this relevant clinical population to determine the presence of the disorder, independently from the test result. In this sampling design, often referred to as <italic>simple random sampling</italic> (SRS), the same fraction (e.g., 10%) of screened positive and negative test results is verified. As the conditions of interest with PSIs are usually rare (most event rates are less than 2%), large samples are needed, and most subjects have negative test results and do not have the condition. This approach results in large expenditures devoted to data collection in subjects who are clinically less relevant than those with the condition of interest. More efficient sampling strategies have been proposed, depending on study design (either prospective or retrospective) and the existence of prior knowledge of prevalence of the condition in different strata of risk factors.<sup><xref ref-type="bibr" rid="bibr16-0272989X11426176">16</xref></sup> When the true condition is already known, a retrospective case-control design (where sampling is done from 2 lists of patients: with and without the target adverse event) may be used. This is, however, not feasible with most PSIs, as the presence or absence of a PSI target condition is generally unknown ahead of chart review.</p>
<p>When sensitivity is predictable in subgroups of persons, an alternative design is <italic>stratified random sampling</italic> (STR). In this approach, the target population is divided into exhaustive and nonoverlapping groups (i.e., strata) of different levels of sensitivity, and SRS is drawn in each stratum for verification. The more homogeneous the sensitivity is within and heterogeneous across strata, the larger the gain of efficiency.<sup><xref ref-type="bibr" rid="bibr17-0272989X11426176">17</xref></sup> The difficulty here, however, lies in identifying those strata. If the prevalence of the condition is related to sensitivity, then stratification by expected prevalence may prove useful.<sup><xref ref-type="bibr" rid="bibr16-0272989X11426176">16</xref></sup> The gain of efficiency over SRS, however, largely depends on the true relationship between prevalence and sensitivity, which has not yet been studied for PSIs. Misclassification errors depend mainly on the quality of medical information encoding, which may or may not be related to prevalence of the condition. But more importantly, coding errors, missing codes, and coding practices vary markedly across hospitals or settings. STR is indeed an interesting approach, but validation studies (where the true condition is being assessed) are prerequisites to devise appropriate strata based on sensitivity prediction through multivariable risk modeling.</p>
<p>Another approach, which has a long history in survey sampling, is to enroll participants prospectively according to test results and to determine the true condition afterwards; thus, one may oversample positively screened subjects for verification on chart reviews and reduce the large number of negative test results to verify. This selective sampling scheme has been referred to as <italic>2-phase sampling</italic> or <italic>verification-biased sampling</italic> (VBS) because, unless properly accommodated, estimates of sensitivity and specificity are biased (<xref ref-type="table" rid="table1-0272989X11426176">Table 1</xref>).<sup><xref ref-type="bibr" rid="bibr16-0272989X11426176">16</xref>,<xref ref-type="bibr" rid="bibr18-0272989X11426176">18</xref></sup> When disease prevalence is low but the main study goal is nonetheless to estimate sensitivity, Irwig and others have shown that, for a given CI width, a VBS design can provide substantial savings in the sample size required for verification.<sup><xref ref-type="bibr" rid="bibr19-0272989X11426176">19</xref></sup> A recent validation study of one PSI (PSI 12) used a VBS design with a fixed number of positive and negative cases verified.<sup><xref ref-type="bibr" rid="bibr20-0272989X11426176">20</xref></sup></p>
<table-wrap id="table1-0272989X11426176" position="float">
<label>Table 1</label>
<caption>
<p>2 × 2 Contingency Table Cross-Classifying Test Results and True Condition Status in Simple Random Sampling and Verification-Biased Sampling</p>
</caption>
<graphic alternate-form-of="table1-0272989X11426176" xlink:href="10.1177_0272989X11426176-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">Complete Data (<italic>N</italic>)</th>
<th align="center" colspan="2">Selected Data (<italic>n</italic>)</th>
</tr>
<tr>
<th/>
<th align="center">D = 1</th>
<th align="center">D = 0</th>
<th align="center">D = 1</th>
<th align="center">D = 0</th>
</tr>
</thead>
<tbody>
<tr>
<td>Y = 1</td>
<td>a</td>
<td>b</td>
<td>a<sup>&amp;</sup></td>
<td>b<sup>&amp;</sup></td>
</tr>
<tr>
<td>Y = 0</td>
<td>c</td>
<td>d</td>
<td>c<sup>&amp;</sup></td>
<td>d<sup>&amp;</sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0272989X11426176">
<p>Note: D denotes the true condition (1 present, 0 absent), that is, the adverse event identified by review of the medical record; Y is the result of the diagnostic test (1 positive, 0 negative), that is, the Patient Safety Indicator (PSI) event identified by the algorithm applied to the administrative data; a<sup>&amp;</sup> = f<sub>1</sub> * a and b<sup>&amp;</sup> = f<sub>1</sub> * b, where f<sub>1</sub> is the verification sampling fraction for positive test results; c<sup>&amp;</sup> = f<sub>0</sub> * c and d<sup>&amp;</sup> = f<sub>0</sub> * d, where f<sub>0</sub> is the verification sampling fraction for negative test results. Usually, f<sub>0</sub> &lt; f<sub>1</sub>, and apparent estimates of sensitivity a<sup>&amp;</sup>/(a<sup>&amp;</sup> + c<sup>&amp;</sup>) and specificity d<sup>&amp;</sup>/(b<sup>&amp;</sup> + d<sup>&amp;</sup>) in selected data are biased.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Comparing sample sizes in settings with and without various screening constraints would be useful. Such constraints arise, for example, when screening has not yet occurred and diagnostic tests are inconvenient or even dangerous (invasive test) or costly. In PSI accuracy studies, one may wish to minimize both the size of the screened population because of the small size of the hospital, the long accrual time required to gather a large enough screened population, and the sample size for verification (e.g., because of resource constraints). The 2 goals, however, contradict, as the size of the screened population does have an impact, albeit relatively small, on the sample size for verification. Furthermore, the minimal required size of the screened population depends considerably on the sampling design one wishes to adopt for verification, for example, SRS, VBS with optimal, or VBS with predefined fixed sampling fractions. For instance, when screening is costly or inconvenient, VBS with optimal sampling fractions (which often requires a very large screened population) may not always be the best solution. A better compromise may be reached by sampling using nonoptimal (i.e., predetermined or fixed) fractions. In other settings, the investigator may desire to verify all positive test results (where likely most clinically meaningful patients are found) and only a fixed or minimal fraction of negative test results.</p>
<p>Our goal was, therefore, to compare the efficiency of various sampling designs (SRS v. VBS), in settings with and without constraints on the screened population, in the context of PSI accuracy studies. Simulation scenarios are presented using previously published rates of PSI true condition and PSI accuracy.</p>
<sec id="section1-0272989X11426176" sec-type="methods">
<title>Methods</title>
<p>In this section, we describe how to compute estimators for parameters of a diagnostic test (in our case, PSI screening algorithms applied to administrative data) and how to estimate sample sizes when a VBS design has been used.</p>
<sec id="section2-0272989X11426176">
<title>Point Estimators of Screening Algorithm Accuracy</title>
<p>The left part of <xref ref-type="table" rid="table1-0272989X11426176">Table 1</xref> summarizes the complete data set from a random sample of <italic>N</italic> subjects drawn from a relevant clinical population. All <italic>N</italic> subjects are tested and verified for accuracy on chart review. The sensitivity (estimated by a/(a + c)) is the proportion of diseased subjects (i.e., inpatients with the specified adverse event found in the medical record) declared positive by the screening tool (i.e., the algorithm applied to hospital routinely collected data). The specificity (estimated by d/(b + d)) is the proportion of nondiseased subjects (inpatients with no specified adverse event in the medical record) declared negative by the screening tool. The PPV is estimated by a/(a + b), and the NPV by d/(c + d).</p>
<p>The right part of <xref ref-type="table" rid="table1-0272989X11426176">Table 1</xref> summarizes the data set from a VBS situation where unequal fractions f<sub>0</sub> of negative test results and f<sub>1</sub> of positive test results have been sampled. Because usually a smaller fraction of observations with negative results undergo confirmatory testing (i.e., f<sub>0</sub> &lt; f<sub>1</sub>), the apparent sensitivity (i.e., a<sup>&amp;</sup>/(a<sup>&amp;</sup> + c<sup>&amp;</sup>)) is overestimated and the apparent specificity (i.e., d<sup>&amp;</sup>/(b<sup>&amp;</sup> + d<sup>&amp;</sup>)) underestimated. However, PPV (i.e., a<sup>&amp;</sup>/(a<sup>&amp;</sup> + b<sup>&amp;</sup>)) and NPV (i.e., d<sup>&amp;</sup>/(c<sup>&amp;</sup> + d<sup>&amp;</sup>)) estimates are unbiased, provided negative and positive screen results have been sampled at random. According to this so-called missing at random (MAR) assumption, the decision to ascertain disease is independent of the true status. Using the Bayes formula and unbiased estimates of predictive values allows us to derive unbiased estimates of sensitivity and specificity in the selected data as follows (variables Y and D are defined in <xref ref-type="table" rid="table1-0272989X11426176">Table 1</xref>):</p>
<p><disp-formula id="disp-formula1-0272989X11426176">
<mml:math display="block" id="math1-0272989X11426176">
<mml:mtable columnalign="left">
<mml:mtr>
<mml:mtd>
<mml:mtext>Se</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mtext>PPV</mml:mtext>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>/</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mtext>PPV</mml:mtext>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>*</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>/</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>,</mml:mo>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula1-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq1.tif"/>
</disp-formula>
</p>
<p>where</p>
<p><disp-formula id="disp-formula2-0272989X11426176">
<mml:math display="block" id="math2-0272989X11426176">
<mml:mrow>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula2-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq2.tif"/>
</disp-formula>
</p>
<p>and</p>
<p><disp-formula id="disp-formula3-0272989X11426176">
<mml:math display="block" id="math3-0272989X11426176">
<mml:mrow>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>|</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>|</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula3-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq3.tif"/>
</disp-formula>
</p>
<p>Since</p>
<p><disp-formula id="disp-formula4-0272989X11426176">
<mml:math display="block" id="math4-0272989X11426176">
<mml:mrow>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mtext>PPV</mml:mtext>
<mml:mspace width="0.5em"/>
<mml:mtext>and</mml:mtext>
<mml:mspace width="0.5em"/>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>|</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mtext>NPV</mml:mtext>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula4-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq4.tif"/>
</disp-formula>
</p>
<p>we have</p>
<p><disp-formula id="disp-formula5-0272989X11426176">
<mml:math display="block" id="math5-0272989X11426176">
<mml:mrow>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mtext>PPV</mml:mtext>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mtext>NPV</mml:mtext>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula5-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq5.tif"/>
</disp-formula>
</p>
<p>and</p>
<p><disp-formula id="disp-formula6-0272989X11426176">
<mml:math display="block" id="math6-0272989X11426176">
<mml:mrow>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>D</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mtext>NPV</mml:mtext>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mtext>PPV</mml:mtext>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>*</mml:mo>
<mml:mtext>P</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mtext>Y</mml:mtext>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula6-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq6.tif"/>
</disp-formula>
</p>
<p>Note that P(Y = 1) is estimated on the full data set.</p>
</sec>
<sec id="section3-0272989X11426176">
<title>Calculating Sample Sizes</title>
<p>The sample size estimates are based on the desired width of the 100(1 – α)% CI for sensitivity. We focused on sensitivity because, in situations where the prevalence of a condition is low, the same level of precision for specificity requires smaller sample sizes than for sensitivity.<sup><xref ref-type="bibr" rid="bibr21-0272989X11426176">21</xref></sup> Moreover, in situations of very low prevalence, less than 0.01 for instance, the negative test result proportion provides a good approximation for specificity. Actually, the negative test result proportion provides a lower bound for specificity, whereas the negative test result proportion plus the prevalence provides an upper bound.<sup><xref ref-type="bibr" rid="bibr1-0272989X11426176">1</xref></sup></p>
<p>For an SRS design, the CI for sensitivity can be calculated using the traditional formula for the CI of a binomial proportion; notice that the exact boundaries cannot, in general, be expressed with an explicit formula, and a very good approximate for an 100(1 – α)% CI is given by</p>
<p><disp-formula id="disp-formula7-0272989X11426176">
<mml:math display="block" id="math7-0272989X11426176">
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:msub>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>n</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>+</mml:mo>
<mml:msubsup>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:msqrt>
<mml:mrow>
<mml:msubsup>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mo>{</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
<mml:mo>+</mml:mo>
<mml:mn>4</mml:mn>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msqrt>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>+</mml:mo>
<mml:msubsup>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msubsup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula7-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq7.tif"/>
</disp-formula>
</p>
<p><disp-formula id="disp-formula8-0272989X11426176">
<mml:math display="block" id="math8-0272989X11426176">
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:msub>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mi>U</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>n</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>+</mml:mo>
<mml:msubsup>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:msqrt>
<mml:mrow>
<mml:msubsup>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msubsup>
<mml:mo>−</mml:mo>
<mml:mo>{</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>+</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>}</mml:mo>
<mml:mo>+</mml:mo>
<mml:mn>4</mml:mn>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>n</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msqrt>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>+</mml:mo>
<mml:msubsup>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msubsup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula8-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq8.tif"/>
</disp-formula>
</p>
<p>where <italic>Z</italic><sub>1−α/2</sub> is the critical value of the standard normal distribution cutting off probability 1−α/2 in the upper tail, and <italic>n</italic> is the sample size of subjects with the condition.<sup><xref ref-type="bibr" rid="bibr22-0272989X11426176">22</xref></sup></p>
<p>For the VBS design, asymptotic 100(1 – α)% CIs for sensitivity and specificity are derived using the asymptotic variance formulas of Begg and Greenes (Appendix, section 1).<sup><xref ref-type="bibr" rid="bibr23-0272989X11426176">23</xref></sup> As previously shown by Irwig and others<sup><xref ref-type="bibr" rid="bibr19-0272989X11426176">19</xref></sup> (<xref ref-type="disp-formula" rid="disp-formula13-0272989X11426176">equation 4</xref> in Appendix, section 1), the optimal sampling design, that is, the smallest number <italic>n</italic> of subjects selected for verification in the screened population of size <italic>N</italic> &gt; <italic>n</italic>, for a desired CI width can be calculated as follows. First, find the optimal sampling fraction ω<sub><italic>opt</italic></sub> of positive test results that minimizes the variance of the sensitivity:</p>
<p><disp-formula id="disp-formula9-0272989X11426176">
<mml:math display="block" id="math9-0272989X11426176">
<mml:mrow>
<mml:msub>
<mml:mi>ω</mml:mi>
<mml:mrow>
<mml:mi>o</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>+</mml:mo>
<mml:msqrt>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>+</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>p</mml:mi>
<mml:mo>−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:mfrac>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula9-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq9.tif"/>
</disp-formula>
</p>
<p>It is remarkable indeed that this optimal value only depends on the expected sensitivity and specificity. Then, given this optimal fraction and the required variance of sensitivity, the minimal number of subjects required for verification can be calculated for the various screening settings and sampling designs (Appendix, section 2). The formulas in the Appendix (section 2) are slightly more general than those provided by Irwig and others<sup><xref ref-type="bibr" rid="bibr19-0272989X11426176">19</xref></sup> and allow readers to specify fixed (i.e., predetermined or nonoptimal) sampling fractions (e.g., f<sub>1</sub> = 1 and f<sub>0</sub> = 0.1). This may be particularly useful in the setting with screening constraints, where these fractions influence notably the required size of the screened population. Also, even without screening constraints, fixed fractions may be useful when the investigator wishes to verify all positive test results and determine the smallest negative sampling fraction required.</p>
<p>The impact of the different screening settings and sampling designs was assessed by the consecutive change in percentage of the sample size of subjects to be verified for a specified CI width for sensitivity. We also examined the expected precision of other parameters of each algorithm and the ratio of reviews on true cases (i.e., all hospitalizations with the event of interest) and reviews on noncases (i.e., hospitalizations where no adverse event was identified). All calculations were conducted using STATA version 10.1 (STATA Corporation, College Station, TX).</p>
</sec>
<sec id="section4-0272989X11426176">
<title>Examples</title>
<p>Eighteen PSIs (7 for surgery, 3 for deliveries, and 8 for medical or surgical stays) have recently been endorsed and updated by the AHRQ from the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes.<sup><xref ref-type="bibr" rid="bibr24-0272989X11426176">24</xref></sup> Based on the original AHRQ ICD-9-CM PSIs, corresponding ICD-10 coding algorithms to screen administrative data for the events of interest have been developed through a process of translation by an international group of health service researchers.<sup><xref ref-type="bibr" rid="bibr25-0272989X11426176">25</xref></sup> Among them, 3 PSIs that reflected rather contrasted frequencies in empirical analyses conducted by the AHRQ on a large sample of a hospitalized population in the United States were considered in our study: PSI 18, obstetric trauma–vaginal delivery with instrument (22.4%); PSI 19, obstetric trauma–vaginal delivery without instrument (8.6%); and PSI 3, decubitus ulcer (2.1%).<sup><xref ref-type="bibr" rid="bibr26-0272989X11426176">26</xref></sup> The source population for applying the 3 algorithms was all patients &gt;18 years old hospitalized in the Centre Hospitalier Universitaire Vaudois (CHUV), an academic medical center in Switzerland, who were discharged between 1 January 2002 and 31 December 2004 after a length of stay of 1 day or more. The population at risk was selected according to the AHRQ specifications.<sup><xref ref-type="bibr" rid="bibr24-0272989X11426176">24</xref></sup> Inclusion and exclusion criteria required various combinations of several variables among routinely collected diagnostic and procedure code data, diagnosis-related group specifications, age, and length of stay.</p>
<p>Prevalences (i.e., P(D = 1) in our notations) of each of the 3 conditions were estimated based on a focused search of the recent relevant literature and discussions with medical consultants who work at the CHUV. Published proportions of patients with clinical third- or fourth-degree perineal lacerations after instrumental delivery (i.e., PSI 18) indicate wide variations, from 4% to over 20%.<sup><xref ref-type="bibr" rid="bibr27-0272989X11426176">27</xref>–<xref ref-type="bibr" rid="bibr29-0272989X11426176">29</xref></sup> In normal spontaneous vaginal delivery, severe lacerations (i.e., PSI 19) were less frequent, with less than 1% to 5%.<sup><xref ref-type="bibr" rid="bibr29-0272989X11426176">29</xref></sup> A 1-day prevalence study of overt pressure ulcers (i.e., PSI 3) in 40 hospitals and 7000 patients in Germany in 2002 gave a proportion of 5%.<sup><xref ref-type="bibr" rid="bibr30-0272989X11426176">30</xref></sup> These proportions ranged from 0.8% in the not-at-risk group to 11% in the at-risk group. Large studies in other countries showed comparable results.<sup><xref ref-type="bibr" rid="bibr31-0272989X11426176">31</xref>,<xref ref-type="bibr" rid="bibr32-0272989X11426176">32</xref></sup></p>
<p>Based on the literature and discussions with the medical team, we expected the following proportions for PSIs in the CHUV: 2% for pressure ulcer, 20% for obstetrical trauma with instrumental vaginal delivery, and 3% for trauma without instrumental vaginal delivery.</p>
<p>We also examined which sensitivity values could be expected. The sensitivity of the PSIs to measure third- and fourth-degree perineal lacerations exceeded 75% in the study of Romano and others.<sup><xref ref-type="bibr" rid="bibr15-0272989X11426176">15</xref></sup> However, less than 70% of other types of obstetrical trauma were coded. In our analyses, the sensitivity of pressure ulcer coding was considered to be only 30% because the documentation of this condition is often inconsistent. Berlowitz and others found that the hospital discharge data set captured the occurrence of pressure ulcers in only 31% of cases.<sup><xref ref-type="bibr" rid="bibr33-0272989X11426176">33</xref></sup> The sensitivity of obstetrical trauma was considered fair (70%) in instrumental assisted deliveries. We used a more pessimistic estimate of sensitivity for normal spontaneous deliveries (50%) because these procedures often are not conducted by medical doctors. We considered, in addition, a fourth scenario with a very low prevalence of true events (0.5%) and poor sensitivity because proportions in no less than 10 PSIs were found to be smaller than 1%.<sup><xref ref-type="bibr" rid="bibr25-0272989X11426176">25</xref>,<xref ref-type="bibr" rid="bibr34-0272989X11426176">34</xref></sup></p>
<p>In the next section, using these 4 examples, we contrasted the impact of the different screening settings and sampling strategies on the sample sizes of persons screened and verified.</p>
</sec>
</sec>
<sec id="section5-0272989X11426176" sec-type="results">
<title>Results</title>
<p><xref ref-type="table" rid="table2-0272989X11426176">Table 2</xref> displays the characteristics of the screened populations when screening of an entire population can be done easily with no cost constraints. The pressure ulcer rate generated by the screening algorithm was about 1%. Obstetrical trauma during vaginal delivery without instruments was present in 2% of screened patients, and obstetrical trauma during vaginal delivery with instruments was present in 19% of screened patients.</p>
<table-wrap id="table2-0272989X11426176" position="float">
<label>Table 2</label>
<caption>
<p>Characteristics of the Screened Populations for Each Selected Patient Safety Indicator (PSI): Decubitus Ulcer, Obstetric Trauma–Vaginal Delivery without Instrument, and Obstetric Trauma–Vaginal Delivery with Instrument</p>
</caption>
<graphic alternate-form-of="table2-0272989X11426176" xlink:href="10.1177_0272989X11426176-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">PSI 3<sup><xref ref-type="table-fn" rid="table-fn2-0272989X11426176">a</xref></sup></th>
<th align="center">PSI 19<sup><xref ref-type="table-fn" rid="table-fn3-0272989X11426176">b</xref></sup></th>
<th align="center">PSI 18<sup><xref ref-type="table-fn" rid="table-fn4-0272989X11426176">c</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td>Size of screened population</td>
<td>33,318</td>
<td>3135</td>
<td>448</td>
</tr>
<tr>
<td>Mean age, y</td>
<td>62.1</td>
<td>29.7</td>
<td>29.2</td>
</tr>
<tr>
<td>Median length of stay, d</td>
<td>15.1</td>
<td>5.1</td>
<td>5.4</td>
</tr>
<tr>
<td>Observed positive test result proportion</td>
<td>0.007</td>
<td>0.020</td>
<td>0.187</td>
</tr>
<tr>
<td>Expected prevalence of the condition<sup><xref ref-type="table-fn" rid="table-fn5-0272989X11426176">d</xref></sup></td>
<td>0.020</td>
<td>0.030</td>
<td>0.20</td>
</tr>
<tr>
<td>Expected sensitivity<sup><xref ref-type="table-fn" rid="table-fn5-0272989X11426176">d</xref></sup> (desired 95% confidence interval width)</td>
<td>0.30 (0.20)</td>
<td>0.50 (0.30)</td>
<td>0.70 (0.30)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0272989X11426176">
<label>a.</label>
<p>Decubitus ulcer.</p>
</fn>
<fn id="table-fn3-0272989X11426176">
<label>b.</label>
<p>Obstetric trauma–vaginal delivery without instrument.</p>
</fn>
<fn id="table-fn4-0272989X11426176">
<label>c.</label>
<p>Obstetric trauma–vaginal delivery with instrument.</p>
</fn>
<fn id="table-fn5-0272989X11426176">
<label>d.</label>
<p>From literature review and hospital team discussion.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The VBS design allowed us to reduce the required sample size for verification for the 4 indicators (<xref ref-type="table" rid="table3-0272989X11426176">Table 3</xref>). The reduction was larger in situations of low prevalence and low sensitivity. Also, the sample size reduction was greater for the screen-constrained setting.</p>
<table-wrap id="table3-0272989X11426176" position="float">
<label>Table 3</label>
<caption>
<p>Reduction in Verified Sample Size to Achieve a Fixed 95% Confidence Interval Width by Verification-Biased Sampling (VBS) Compared to Simple Random Sampling According to Screening Setting</p>
</caption>
<graphic alternate-form-of="table3-0272989X11426176" xlink:href="10.1177_0272989X11426176-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Screening Setting</th>
<th align="center">Sampling Design</th>
<th align="center">Population Screened (<italic>N</italic>)</th>
<th align="center">Sampled Fractions of Positive (f<sub>1</sub>) and Negative Test Results (f<sub>0</sub>)</th>
<th align="center">No. of Positive Test Results (Proportion in %)<sup><xref ref-type="table-fn" rid="table-fn7-0272989X11426176">a</xref></sup></th>
<th align="center">No. of Negative Test Results</th>
<th align="center">Verified Sample Size (<italic>n</italic>)</th>
<th align="center">Sample Size Reduction, %<sup><xref ref-type="table-fn" rid="table-fn8-0272989X11426176">b</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="8">PSI 3</td>
</tr>
<tr>
<td> Constrained</td>
<td>Random</td>
<td>3954</td>
<td>1, 1</td>
<td>28 (0.7)</td>
<td>3926</td>
<td>3954</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>10,882</td>
<td>1, 0.14</td>
<td>76 (4.7)</td>
<td>1560</td>
<td>1636</td>
<td>59</td>
</tr>
<tr>
<td> Unconstrained</td>
<td>Random</td>
<td>33,318</td>
<td>0.051, 0.051</td>
<td>12 (0.7)</td>
<td>1674</td>
<td>1686</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>33,318</td>
<td>0.275, 0.039</td>
<td>64 (4.7)</td>
<td>1311</td>
<td>1375</td>
<td>18</td>
</tr>
<tr>
<td colspan="8">PSI 19</td>
</tr>
<tr>
<td> Constrained</td>
<td>Random</td>
<td>1337</td>
<td>1, 1</td>
<td>27 (2.0)</td>
<td>1310</td>
<td>1337</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>3000</td>
<td>1, 0.28</td>
<td>60 (6.7)</td>
<td>834</td>
<td>894</td>
<td>33</td>
</tr>
<tr>
<td> Unconstrained</td>
<td>Random</td>
<td>3135</td>
<td>0.315, 0.315</td>
<td>20 (2.0)</td>
<td>967</td>
<td>987</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>3135</td>
<td>0.957, 0.255</td>
<td>59 (6.7)</td>
<td>826</td>
<td>885</td>
<td>10</td>
</tr>
<tr>
<td colspan="8">PSI 18</td>
</tr>
<tr>
<td> Constrained</td>
<td>Random</td>
<td>172</td>
<td>1, 1</td>
<td>32 (18.6)</td>
<td>140</td>
<td>172</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>177</td>
<td>0.71, 1</td>
<td>24 (14.3)</td>
<td>144</td>
<td>168</td>
<td>2</td>
</tr>
<tr>
<td> Unconstrained</td>
<td>Random</td>
<td>448</td>
<td>0.31, 0.31</td>
<td>26 (18.7)</td>
<td>113</td>
<td>139</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>448</td>
<td>0.22, 0.37</td>
<td>19 (13.9)</td>
<td>118</td>
<td>137</td>
<td>1</td>
</tr>
<tr>
<td colspan="8">PSI “low occurrence” (hypothetical)<sup><xref ref-type="table-fn" rid="table-fn9-0272989X11426176">c</xref></sup></td>
</tr>
<tr>
<td> Constrained</td>
<td>Random</td>
<td>15,813</td>
<td>1, 1</td>
<td>158 (1)</td>
<td>15,655</td>
<td>15,813</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>77,442</td>
<td>1, 0.071</td>
<td>774 (12.4)</td>
<td>5461</td>
<td>6235</td>
<td>61</td>
</tr>
<tr>
<td> Unconstrained</td>
<td>Random</td>
<td>100,000</td>
<td>0.144, 0.144</td>
<td>144 (1)</td>
<td>14,233</td>
<td>14,377</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>100,000</td>
<td>0.773, 0.054</td>
<td>771 (12.4)</td>
<td>5434</td>
<td>6205</td>
<td>57</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0272989X11426176">
<p>Note: PSI = Patient Safety Indicator.</p>
</fn>
<fn id="table-fn7-0272989X11426176">
<label>a.</label>
<p>Notice that the positive test result proportion in the sample equals the positive test result proportion in the screened population in the random sampling design.</p>
</fn>
<fn id="table-fn8-0272989X11426176">
<label>b.</label>
<p>(Sample size using random design – Sample size using VBS)/Sample size using random design.</p>
</fn>
<fn id="table-fn9-0272989X11426176">
<label>c.</label>
<p>Sensitivity = 0.3; 95% sensitivity confidence interval width = 0.2; P(D = 1) = 0.005; P(Y = 1) = 0.01.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p><xref ref-type="table" rid="table4-0272989X11426176">Table 4</xref> shows that the VBS was more efficient for PSI 3 decubitus ulcer, PSI 19 obstetric trauma–vaginal delivery without instrument, and the hypothetical fourth scenario. The precision of the other parameters of the tests was consistently better and the proportion of reviews on actual quality issues higher. For PSI 18 (fair sensitivity and higher prevalence), the VBS approach was not useful, leading to decreased precision of the PPV and a decreased proportion of reviewed cases with an actual true condition encountered. The reason is that the optimal strategy resulted in undersampling of positive test results, as shown in <xref ref-type="table" rid="table3-0272989X11426176">Table 3</xref>.</p>
<table-wrap id="table4-0272989X11426176" position="float">
<label>Table 4</label>
<caption>
<p>Comparison of the Efficiency of Verification-Biased Sampling (VBS) versus Equal Sampling of Positive and Negative Test Results for Accuracy Checking</p>
</caption>
<graphic alternate-form-of="table4-0272989X11426176" xlink:href="10.1177_0272989X11426176-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th/>
<th align="center" colspan="4">95% Confidence Intervals around Estimates, %<sup><xref ref-type="table-fn" rid="table-fn11-0272989X11426176">a</xref></sup></th>
<th/>
</tr>
<tr>
<th align="left">Screening Setting</th>
<th align="center">Sampling Design</th>
<th align="center">Sample Size</th>
<th align="center">Sensitivity</th>
<th align="center">Specificity</th>
<th align="center">PPV</th>
<th align="center">NPV</th>
<th align="center">True Case Rate Ratio<sup><xref ref-type="table-fn" rid="table-fn12-0272989X11426176">b</xref></sup></th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="8">PSI 3</td>
</tr>
<tr>
<td> Constrained</td>
<td>Random</td>
<td>3954</td>
<td>21–41</td>
<td>100–100</td>
<td>67–96</td>
<td>98–99</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>1636</td>
<td>21–41</td>
<td>100–100</td>
<td>76–93</td>
<td>98–99</td>
<td>2.7</td>
</tr>
<tr>
<td> Unconstrained</td>
<td>Random</td>
<td>1686</td>
<td>21–41</td>
<td>100–100</td>
<td>52–98</td>
<td>98–99</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>1375</td>
<td>21–41</td>
<td>100–100</td>
<td>75–93</td>
<td>98–99</td>
<td>2.6</td>
</tr>
<tr>
<td colspan="8">PSI 19</td>
</tr>
<tr>
<td> Constrained</td>
<td>Random</td>
<td>1337</td>
<td>35–65</td>
<td>99–100</td>
<td>54–89</td>
<td>98–99</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>894</td>
<td>35–65</td>
<td>99–100</td>
<td>62–85</td>
<td>97–99</td>
<td>2.2</td>
</tr>
<tr>
<td> Unconstrained</td>
<td>Random</td>
<td>987</td>
<td>35–65</td>
<td>99–100</td>
<td>51–91</td>
<td>97–99</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>885</td>
<td>35–65</td>
<td>99–100</td>
<td>63–86</td>
<td>97–99</td>
<td>2.1</td>
</tr>
<tr>
<td colspan="8">PSI 18</td>
</tr>
<tr>
<td> Constrained</td>
<td>Random</td>
<td>172</td>
<td>53–83</td>
<td>89–97</td>
<td>57–89</td>
<td>87–97</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>168</td>
<td>53–83</td>
<td>88–97</td>
<td>53–90</td>
<td>88–97</td>
<td>0.8</td>
</tr>
<tr>
<td> Unconstrained</td>
<td>Random</td>
<td>139</td>
<td>53–83</td>
<td>89–97</td>
<td>52–88</td>
<td>85–96</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>137</td>
<td>53–83</td>
<td>88–97</td>
<td>49–91</td>
<td>85–96</td>
<td>0.9</td>
</tr>
<tr>
<td colspan="8">PSI hypothetical</td>
</tr>
<tr>
<td> Constrained</td>
<td>Random</td>
<td>15,813</td>
<td>21–41</td>
<td>99–99</td>
<td>10–22</td>
<td>100–100</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>6235</td>
<td>21–41</td>
<td>99–99</td>
<td>13–18</td>
<td>99–100</td>
<td>4.3</td>
</tr>
<tr>
<td> Unconstrained</td>
<td>Random</td>
<td>14,377</td>
<td>21–41</td>
<td>99–99</td>
<td>10–22</td>
<td>100–100</td>
<td/>
</tr>
<tr>
<td/>
<td>VBS</td>
<td>6205</td>
<td>21–41</td>
<td>99–99</td>
<td>13–18</td>
<td>99–100</td>
<td>4.3</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn10-0272989X11426176">
<p>Note: PPV = positive predictive value; NPV = negative predictive value; PSI = Patient Safety Indicator.</p>
</fn>
<fn id="table-fn11-0272989X11426176">
<label>a.</label>
<p>The values presented have been rounded to the integer.</p>
</fn>
<fn id="table-fn12-0272989X11426176">
<label>b.</label>
<p>Ratio of the proportions of subjects who have the condition among the verified sample using VBS and simple random sampling design.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Although VBS is more efficient in general, validation studies of most PSIs that screen very rare events will require, for a prevalence of positive test results similar to the disease prevalence, still over 5000 to 6000 medical record reviews (<xref ref-type="table" rid="table3-0272989X11426176">Tables 3</xref> and <xref ref-type="table" rid="table4-0272989X11426176">4</xref>, hypothetical PSI). Moreover, it dictates a need to screen large populations, even within a minimal screen-constrained setting (<italic>N</italic> = 77,442).</p>
</sec>
<sec id="section6-0272989X11426176" sec-type="discussion">
<title>Discussion</title>
<p>We have illustrated with real data that selectively sampling positive and negative test results based on optimally calculated fractions can reduce the number of medical records that need to be checked to make a valid assessment of patient safety. However, because the conditions to be detected by PSIs are typically of low prevalence, the sample of subjects required for verification will still be quite large. Other sampling strategies, such as stratified 2-stage sampling may prove very useful once appropriate strata have been defined. In the case of PSI studies, this is, however, a difficult task, which requires further research, as the population has to be stratified according to sensitivity and not simply prevalence.</p>
<p>Compared to SRS, VBS can notably reduce the sample size required for estimating the sensitivity of PSIs with specified precision, especially if the expected sensitivity is low. Moreover, PPV, NPV, and specificity are almost always estimated with greater precision than by SRS. Furthermore, the review will generate more useful information because hospitalizations with a higher risk of safety issues are oversampled. Our findings concur with the few previous publications on optimal designs for the estimation of sensitivity and specificity for a broader range of expected values of sensitivity, specificity, and prevalence. These studies have shown that the VBS design is more effective when sensitivity is low to moderate (&lt;0.7) and prevalence is low (≤0.1) and much less when sensitivity increases over 0.8.<sup><xref ref-type="bibr" rid="bibr21-0272989X11426176">21</xref></sup> In cases of very high prevalence (&gt;0.5), however, the arguments are reversed, and savings are greater for higher sensitivities.</p>
<p>Because the major cost of accuracy studies of PSIs is the verification of the condition in the medical record, the VBS method can be recommended for most indicators with an expected prevalence over 1%, where sample size for verification is manageable. In the US data, PSI prevalences have varied from less than 0.01% to 25%; some misadventures like transfusion errors or foreign bodies left in during a procedure were indeed rare events.<sup><xref ref-type="bibr" rid="bibr26-0272989X11426176">26</xref></sup> Incidentally, the PSI prevalences observed in our study are in agreement with published proportions from other countries.<sup><xref ref-type="bibr" rid="bibr8-0272989X11426176">8</xref>,<xref ref-type="bibr" rid="bibr35-0272989X11426176">35</xref></sup> Given that the expected true prevalence of most targeted safety events probably does not exceed 2%, even using an optimal VBS design will still require large, and costly, validity studies. In most cases, over 1000 medical records should be reviewed. In addition, using the VBS approach means that a very large population needs to be screened. Thus, study duration may turn out to be prohibitive, particularly when it may not be possible or convenient to gather information from different hospitals. For instance, in our hypothetical example, to implement the optimal design required about 80,000 subjects, from which less than 6500 were selected for verification, compared with around 16,000 for the SRS approach. When sampling is performed in different hospitals, however, there will be some loss of power due to the existence of intrahospital correlation, and the variances and sample size formula given in the text must be adapted.</p>
<p>When cases with a potential safety issue are identifiable from registries, through the hospital reporting system, an alternative option is to conduct a case control study, where the true condition status is the criterion for enrollment and the diagnostic test is assessed. This is, however, seldom feasible in our case because registries of most of the adverse events screened by PSIs are lacking. This design has been used for estimating the sensitivity of coding perineal lacerations and decubitus ulcers in an administrative database in specific situations where detailed clinical information was gathered in a prospective study.<sup><xref ref-type="bibr" rid="bibr33-0272989X11426176">33</xref>,<xref ref-type="bibr" rid="bibr36-0272989X11426176">36</xref></sup> Nevertheless, the case control design has been criticized for overestimating test accuracy (i.e., sensitivity and specificity) when compared with studies recruiting patients without consideration of the disease status.<sup><xref ref-type="bibr" rid="bibr37-0272989X11426176">37</xref></sup> Indeed, more serious events are more likely to be declared in the case registry and also more likely to be coded in the routinely collected discharge record, thereby overestimating sensitivity.</p>
<p>Another possibility is to consider a stratified sampling design, where subjects from subpopulations with higher sensitivities are more heavily sampled. Obuchowksi and others<sup><xref ref-type="bibr" rid="bibr16-0272989X11426176">16</xref></sup> illustrated the potential efficiency gain (in terms of cost savings) from stratifying the target population by a dichotomous factor when the prevalence and sensitivity were different in the 2 sampling strata. Factors for risk stratification, however, are not obvious in PSI diagnostic accuracy studies, where the relationship between prevalence and sensitivity is disputable. When classification of true condition status is based on dichotomization of an underlying continuous trait and in the presence of measurement errors, a relationship between prevalence and sensitivity has been shown to exist.<sup><xref ref-type="bibr" rid="bibr38-0272989X11426176">38</xref></sup> The situation, however, is less clear with PSIs, which are truly dichotomous entities. It is difficult in this setting to anticipate how sensitivity is related to prevalence, as many factors may affect the quality of coding, such as patient case mix, but also diagnostic category, type of hospital or medical service, and so on.<sup><xref ref-type="bibr" rid="bibr39-0272989X11426176">39</xref></sup> Validation studies based on a VBS design would, indeed, be useful to identify factors related to sensitivity. Once these factors have been identified, stratified sampling based on a risk (or propensity) score may be an interesting alternative to VBS, particularly in very low prevalence settings. The gain of efficiency will depend, however, on the homogeneity of within and heterogeneity of between strata sensitivity and, therefore, on how well the propensity score allows prediction of sensitivity. If the model poorly predicts the condition, stratification based on the risk score may not perform well (even worse than SRS in extreme cases).</p>
<p>Furthermore, devising optimal strata, as well as optimally allocating sample sizes between positive and negative test results within each stratum, is rather complex. The number, as well as the location of the cut points, of the strata must be determined, along with optimal Neyman allocation.<sup><xref ref-type="bibr" rid="bibr40-0272989X11426176">40</xref>,<xref ref-type="bibr" rid="bibr41-0272989X11426176">41</xref></sup> In the case of simple random stratified sampling, Neyman allocation depends only on the sensitivity and weight associated with each stratum.<sup><xref ref-type="bibr" rid="bibr42-0272989X11426176">42</xref></sup> However, the extension to VBS within each stratum is less straightforward. Obuchowksi and others<sup><xref ref-type="bibr" rid="bibr16-0272989X11426176">16</xref></sup> did not consider Neyman optimal allocation within strata but rather proposed to verify all positive test results and a fraction of negative test results. This hard topic requires further developments and comparative analyses of the efficiency of these various sampling schemes.</p>
<p>Yet, still another alternative, when previous studies have provided accuracy values, is to verify all positive test results only and compute, in addition to PPV, 2 other parameters of interest: the detection probability (DP), that is, the proportion of subjects that screen positively and have the condition (a/N); and the false referral probability (FP), that is, the proportion of subjects that screen positively and do not have the disease (b/N).<sup><xref ref-type="bibr" rid="bibr43-0272989X11426176">43</xref></sup> These are binomial proportions allowing straightforward calculation of CIs. Like PPV, DP and FP depend on both the prevalence of the condition and the accuracy of the screening test, but they are useful when comparing the accuracy of 2 tests. In fact, the relative ratio of DP is similar to the relative sensitivity and the relative ratio of FP similar to 1 – specificity (i.e., DP<sub>1</sub>/DP<sub>2</sub> = Se<sub>1</sub>/Se<sub>2</sub> and FP<sub>1</sub>/FP<sub>2</sub> = Sp<sub>1</sub>/Sp<sub>2</sub>).</p>
<p>Our work, although motivated by PSI validity studies, can be applied more broadly. It should be particularly useful in any situation where both screening and assessment of the true condition are expensive or invasive and the expected test sensitivity is low, especially when the prevalence is low and the specificity is high, and the true prevalence of the condition is not known in advance. We have written a computer program in STATA (which is available upon request), allowing users not only to find the optimal sampling design but also to fix the level of the desired fractions of positive and negative test results. In applied clinical studies, investigators could actually be more concerned by reducing negative test results to be verified than by minimizing the total number of subjects. Inputting into the software the fractions of positive test results f<sub>1</sub> set to 1 and of negative test results f<sub>0</sub> set to less than 1 allows the comparison of the precision of the fixed fraction sampling design with that of the optimal VBS and random sampling.</p>
<p>The limitations of our study largely overlap with the limitations of the approach itself, which have already been stated. We have applied the proposed scenarios to data obtained from one medical center, a nonrepresentative sample. In addition, the quality of coding may not be perfect, although analyses have proved that quality of coding is high in this hospital. These 2 elements are not crucial for the use of the data we have made. In fact, it is the flaws of administrative data coding that motivate the need for PSI validation studies, for which the VBS design can be considered.</p>
</sec>
</body>
<back>
<app-group>
<app id="app1-0272989X11426176">
<title>Appendix</title>
<sec id="section7-0272989X11426176">
<title>Verification-Biased Sampling Design</title>
<sec id="section8-0272989X11426176">
<title>1. Correction Formula for Sensitivity Variance (Begg and Greenes<sup><xref ref-type="bibr" rid="bibr23-0272989X11426176">23</xref></sup>)</title>
<p>Using the Bayes rule, it is straightforward to establish</p>
<p><disp-formula id="disp-formula10-0272989X11426176">
<mml:math display="block" id="math10-0272989X11426176">
<mml:mtable columnalign="left">
<mml:mtr>
<mml:mtd>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>+</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mtext>logit</mml:mtext>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>=</mml:mo>
<mml:mi>log</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>e</mml:mi>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>=</mml:mo>
<mml:mi>log</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>+</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>−</mml:mo>
<mml:mi>log</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>.</mml:mo>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula10-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq10.tif"/>
</disp-formula>
</p>
<p>Considering a Taylor expansion of order 1 and taking the variance of the estimate of logit (<italic>Se</italic>):</p>
<p><disp-formula id="disp-formula11-0272989X11426176">
<mml:math display="block" id="math11-0272989X11426176">
<mml:mtable columnalign="left">
<mml:mtr>
<mml:mtd>
<mml:mtext>Var</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>≅</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mi>N</mml:mi>
</mml:mfrac>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>+</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>+</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>+</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>−</mml:mo>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula11-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq11.tif"/>
</disp-formula>
</p>
<p>where <italic>N</italic> is the size of the screened population, and <italic>n</italic> + and <italic>n</italic> − represent the number of positive and negative test results considered for verification of condition status.</p>
<p>Assuming asymptotic normality, a 2-sided 100(1 – α)% confidence interval for the logit (<italic>Ŝe</italic>) is provided by</p>
<p><disp-formula id="disp-formula12-0272989X11426176">
<mml:math display="block" id="math12-0272989X11426176">
<mml:mrow>
<mml:mn>100</mml:mn>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mi>%</mml:mi>
<mml:mtext>CI</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>=</mml:mo>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>±</mml:mo>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:msqrt>
<mml:mrow>
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mi>^</mml:mi>
</mml:mover>
<mml:mtext>ar</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msqrt>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula12-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq12.tif"/>
</disp-formula>
</p>
<p>where the variance of logit (<italic>Ŝe</italic>) has been estimated by substituting the sample proportions for the probabilities. Then, back transforming logit (<italic>Ŝe</italic>), one obtains for the sensitivity</p>
<p><disp-formula id="disp-formula13-0272989X11426176">
<mml:math display="block" id="math13-0272989X11426176">
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:msub>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:msqrt>
<mml:mrow>
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mtext>ar</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>+</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:msqrt>
<mml:mrow>
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mtext>ar</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula13-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq13.tif"/>
</disp-formula>
</p>
<p>and</p>
<p><disp-formula id="disp-formula14-0272989X11426176">
<mml:math display="block" id="math14-0272989X11426176">
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:msub>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mi>U</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>P</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>=</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:msqrt>
<mml:mrow>
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mtext>ar</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>+</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>−</mml:mo>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mi>α</mml:mi>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
<mml:msqrt>
<mml:mrow>
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mtext>ar</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mfrac>
<mml:mo>,</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula14-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq14.tif"/>
</disp-formula>
</p>
<p>The procedure for specificity is completely similar.</p>
</sec>
<sec id="section9-0272989X11426176">
<title>2. Number Required for Verification (Irwig and others<sup><xref ref-type="bibr" rid="bibr19-0272989X11426176">19</xref></sup>)</title>
<p>Let <italic>N</italic> be the total number of persons screened, and assume the disease status will be verified in a sample of <italic>n</italic> persons. To allow, in addition, for the simulation of a fixed fraction sampling design where the investigator has decided to verify fixed fractions of positive and negative test results from the screened population, <italic>n</italic> + is replaced, in <xref ref-type="disp-formula" rid="disp-formula11-0272989X11426176">equation 2</xref>, by <italic>NP</italic>(<italic>Y</italic> = 1)<italic>f</italic><sub>1</sub> and <italic>n</italic> − by <italic>N</italic>(1 − <italic>P</italic>(<italic>Y</italic> =1))<italic>f</italic><sub>0</sub>. Setting <italic>f</italic><sub>1</sub> and <italic>f</italic><sub>0</sub> equal to 1 allows verifying a random sample from the screened population. Then, an estimated variance of the estimate of logit (<italic>Se</italic>) is</p>
<p><disp-formula id="disp-formula15-0272989X11426176">
<mml:math display="block" id="math15-0272989X11426176">
<mml:mtable columnalign="left">
<mml:mtr>
<mml:mtd>
<mml:mover accent="true">
<mml:mtext>V</mml:mtext>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mtext>ar</mml:mtext>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mtext>logit</mml:mtext>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mi>e</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
<mml:mo>≅</mml:mo>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mi>N</mml:mi>
</mml:mfrac>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>P</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:mrow>
<mml:mo>[</mml:mo> <mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mover accent="true">
<mml:mi>P</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow> <mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>+</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>P</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mover accent="true">
<mml:mi>P</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>N</mml:mi>
<mml:mover accent="true">
<mml:mi>P</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
<mml:msub>
<mml:mi>f</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mtd>
</mml:mtr>
<mml:mtr>
<mml:mtd>
<mml:mo>+</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>P</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mover accent="true">
<mml:mi>P</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>D</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">|</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>N</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>−</mml:mo>
<mml:mover accent="true">
<mml:mi>P</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>Y</mml:mi>
<mml:mo>=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:msub>
<mml:mi>f</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow> <mml:mo>}</mml:mo>
</mml:mrow>
</mml:mtd>
</mml:mtr>
</mml:mtable>
</mml:math>
<graphic alternate-form-of="disp-formula15-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq15.tif"/>
</disp-formula>
</p>
<p>where <italic>f</italic><sub>1</sub> and <italic>f</italic><sub>0</sub> represent the fractions of subjects for whom the test result is positive and negative, respectively, that are verified for disease status, and P̂ stands for an estimate of the probability.</p>
<p>Finally, for an 100(1 – α)% confidence interval width for <italic>Se</italic> of no more than <italic>d</italic>, the minimum size <italic>n</italic> of the sample of patients needed for verification is found by solving</p>
<p><disp-formula id="disp-formula16-0272989X11426176">
<mml:math display="block" id="math16-0272989X11426176">
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:msub>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mi>U</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>−</mml:mo>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo>^</mml:mo>
</mml:mover>
<mml:msub>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mi>L</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>w</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>≤</mml:mo>
<mml:mi>d</mml:mi>
<mml:mo>.</mml:mo>
</mml:mrow>
</mml:math>
<graphic alternate-form-of="disp-formula16-0272989X11426176" xlink:href="10.1177_0272989X11426176-eq16.tif"/>
</disp-formula>
</p>
<p>Notice, as is clear from <xref ref-type="disp-formula" rid="disp-formula9-0272989X11426176">equation 2</xref>, in the screen-unconstrained setting, <italic>N</italic> is fixed in advance and is usually larger than in the screen-constrained setting, where its minimum value is calculated according to the sampling scheme selected for verification.</p>
</sec>
</sec>
</app>
</app-group>
<ack><p>The IMECCHI (International Methodology Consortium for Coded Health Information) investigators include Bernard Burnand (University of Lausanne, Switzerland), Cyrille Colin (University of Lyon, France), Chantal Couris (University of Lyon, France), Carolyn De Coster (University of Manitoba, Canada), Saskia Drosler (Niederrhein University of Applied Sciences, Germany), Alan Finlayson (National Health Service, Scotland), Kiyohide Fushimi (Tokyo Medical and Dental University Graduate School, Japan), Min Gao (British Columbia Provincial Public Health Services Authority, Canada), William Ghali (University of Calgary, Canada), Patricia Halfon (University of Lausanne, Switzerland), Brenda Hemmelgarn (University of Calgary, Canada), Karin Humphries (University of British Columbia, Canada), Jean-Marie Januel (University of Lyon, France, and University of Lausanne, Switzerland), Helen Johansen (Statistics Canada, Canada), Lisa Lix (University of Manitoba, Canada), Jean-Christophe Luthi (University of Lausanne, Switzerland), Jin Ma (Jiaotong University, China), Hude Quan (University of Calgary, Canada), Patrick Romano (University of California at Davis), Leslie Roos (University of Manitoba, Canada), Fiona Shrive (University of Calgary, Canada), Vijaya Sundararajan (Victorian Department of Human Services, Australia), Sandrine Touzet (University of Lyon, France), Jack Tu (University of Toronto, Canada), and Greg Webster (Canadian Institute of Health Information, Canada). We thank Lucienne Boujon for copyediting the article. Patrick Taffé, PhD, and Patricia Halfon, MD, contributed equally to this work.</p>
</ack>
<notes>
<fn-group>
<fn fn-type="other" id="fn1-0272989X11426176">
<label>1.</label>
<p>Negative test result proportion = (c + d)/N = Sp – ((a + c)/N) * (Sp + se − 1)), so if (a + c)/N is small, negative proportion is a good approximation of Sp. In helpful tests, the Younden index, defined as (Sp + Se − 1), is greater than 0 but never exceeds 1; thus, negative proportion gives a lower bound for Sp, and negative proportion plus disease prevalence (a + c)/N gives an upper bound.</p>
</fn>
</fn-group>
</notes>
<ref-list>
<ref id="bibr1-0272989X11426176">
<label>1.</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name><surname>Kohn</surname><given-names>LT</given-names></name>
<name><surname>Corrigan</surname><given-names>JM</given-names></name>
<name><surname>Donaldson</surname><given-names>MS</given-names></name>
</person-group>, eds. <article-title>Committee on Quality of Health Care in America, Institute of Medicine</article-title>. <source>To Err Is Human: Building a Safer Health System</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>The National Academies Press</publisher-name>; <year>2000</year>.</citation>
</ref>
<ref id="bibr2-0272989X11426176">
<label>2.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Millar</surname><given-names>J</given-names></name>
<name><surname>Mattke</surname><given-names>S</given-names></name>
</person-group>; <collab>the Members of the OECD Patient Safety Panel</collab>. <article-title>Selecting Indicators for Patient Safety at the Health Systems Level in OECD Countries</article-title>. <comment>OECD technical paper: No. 18</comment>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>Organisation for Economic Co-operation and Development</publisher-name>; <year>2004</year>.</citation>
</ref>
<ref id="bibr3-0272989X11426176">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vincent</surname><given-names>C</given-names></name>
<name><surname>Neale</surname><given-names>G</given-names></name>
<name><surname>Woloshynowych</surname><given-names>M</given-names></name>
</person-group>. <article-title>Adverse events in British hospitals: preliminary retrospective record review</article-title>. <source>BMJ</source>. <year>2001</year>;<volume>322</volume>:<fpage>517</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr4-0272989X11426176">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brennan</surname><given-names>T</given-names></name>
<name><surname>Leape</surname><given-names>L</given-names></name>
<name><surname>Laird</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Incidence of adverse events and negligence in hospitalized patients: results of the Harvard medical practice study I</article-title>. <source>N Engl J Med</source>. <year>1991</year>;<volume>324</volume>:<fpage>370</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr5-0272989X11426176">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>R</given-names></name>
<name><surname>Runciman</surname><given-names>W</given-names></name>
<name><surname>Gibberd</surname><given-names>R</given-names></name>
<name><surname>Harrison</surname><given-names>B</given-names></name>
<name><surname>Newby</surname><given-names>L</given-names></name>
<name><surname>Hamilton</surname><given-names>J</given-names></name>
</person-group>. <article-title>The quality in Australian health care study</article-title>. <source>Med J Aust</source>. <year>1995</year>;<volume>163</volume>:<fpage>458</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr6-0272989X11426176">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baker</surname><given-names>RG</given-names></name>
<name><surname>Norton</surname><given-names>PG</given-names></name>
<name><surname>Flintoft</surname><given-names>V</given-names></name><etal/>
</person-group>. <article-title>The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada</article-title>. <source>Can Med Assoc J</source>. <year>2004</year>;<volume>170</volume>:<fpage>1678</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr7-0272989X11426176">
<label>7.</label>
<citation citation-type="gov">
<collab>Agency for Healthcare Research and Quality</collab>. <article-title>Guide to Patient Safety Indicators, Version 3.1</article-title> (<month>March</month> <day>12</day>, <year>2007</year>). <publisher-loc>Available from</publisher-loc>: <comment><ext-link ext-link-type="uri" xlink:href="http://www.qualityindicators.ahrq.gov/downloads/psi/psi_guide_v31.pdf">http://www.qualityindicators.ahrq.gov/downloads/psi/psi_guide_v31.pdf</ext-link></comment></citation>
</ref>
<ref id="bibr8-0272989X11426176">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhan</surname><given-names>C</given-names></name>
<name><surname>Miller</surname><given-names>MR</given-names></name>
</person-group>. <article-title>Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization</article-title>. <source>JAMA</source>. <year>2003</year>;<volume>290</volume>:<fpage>1868</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr9-0272989X11426176">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aylin</surname><given-names>P</given-names></name>
<name><surname>Tanna</surname><given-names>S</given-names></name>
<name><surname>Bottle</surname><given-names>A</given-names></name>
<name><surname>Jarman</surname><given-names>B</given-names></name>
</person-group>. <article-title>How often are adverse events reported in English hospital statistics?</article-title> <source>BMJ</source>. <year>2004</year>;<volume>329</volume>:<fpage>369</fpage>.</citation>
</ref>
<ref id="bibr10-0272989X11426176">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Romano</surname><given-names>PS</given-names></name>
<name><surname>Chan</surname><given-names>BK</given-names></name>
<name><surname>Schembri</surname><given-names>ME</given-names></name>
<name><surname>Rainwater</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Can administrative data be used to compare postoperative complication rates across hospitals?</article-title> <source>Med Care</source>. <year>2002</year>;<volume>40</volume>:<fpage>856</fpage>–<lpage>67</lpage>.</citation>
</ref>
<ref id="bibr11-0272989X11426176">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Michel</surname><given-names>P</given-names></name>
<name><surname>Quenon</surname><given-names>JL</given-names></name>
<name><surname>de Sarasqueta</surname><given-names>AM</given-names></name>
<name><surname>Scemama</surname><given-names>O</given-names></name>
</person-group>. <article-title>Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals</article-title>. <source>BMJ</source>. <year>2004</year>;<volume>328</volume>:<fpage>199</fpage>–<lpage>203</lpage>.</citation>
</ref>
<ref id="bibr12-0272989X11426176">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Iezzoni</surname><given-names>LI</given-names></name>
<name><surname>Foley</surname><given-names>SM</given-names></name>
<name><surname>Heeren</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>A method for screening the quality of hospital care using administrative data: preliminary validation results</article-title>. <source>Qual Rev Bull</source>. <year>1992</year>;<volume>18</volume>:<fpage>361</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr13-0272989X11426176">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Weingart</surname><given-names>SN</given-names></name>
<name><surname>Iezzoni</surname><given-names>LI</given-names></name>
<name><surname>Davis</surname><given-names>RB</given-names></name>
<etal/>
</person-group>. <article-title>Use of administrative data to find substandard care: validation of the complications screening program</article-title>. <source>Med Care</source>. <year>2000</year>;<volume>38</volume>:<fpage>796</fpage>–<lpage>806</lpage>.</citation>
</ref>
<ref id="bibr14-0272989X11426176">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lawthers</surname><given-names>AG</given-names></name>
<name><surname>McCarthy</surname><given-names>EP</given-names></name>
<name><surname>Davis</surname><given-names>RB</given-names></name>
<name><surname>Peterson</surname><given-names>LE</given-names></name>
<name><surname>Palmer</surname><given-names>RH</given-names></name>
<name><surname>Iezzoni</surname><given-names>LI</given-names></name>
</person-group>. <article-title>Identification of in-hospital complications from claims data: is it valid?</article-title> <source>Med Care</source>. <year>2000</year>;<volume>38</volume>:<fpage>785</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr15-0272989X11426176">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Romano</surname><given-names>PS</given-names></name>
<name><surname>Yasmeen</surname><given-names>S</given-names></name>
<name><surname>Schembri</surname><given-names>ME</given-names></name>
<name><surname>Keyzer</surname><given-names>JM</given-names></name>
<name><surname>Gilbert</surname><given-names>WM</given-names></name>
</person-group>. <article-title>Coding of perineal lacerations and other complications of obstetric care in hospital discharge data</article-title>. <source>Obstet Gynecol</source>. <year>2005</year>;<volume>106</volume>:<fpage>717</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr16-0272989X11426176">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Obuchowski</surname><given-names>NA</given-names></name>
<name><surname>Zhou</surname><given-names>XH</given-names></name>
</person-group>. <article-title>Prospective studies of diagnostic test accuracy when disease prevalence is low</article-title>. <source>Biostatistics</source>. <year>2002</year>;<volume>3</volume>:<fpage>477</fpage>–<lpage>92</lpage>.</citation>
</ref>
<ref id="bibr17-0272989X11426176">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Evans</surname><given-names>WD</given-names></name>
</person-group>. <article-title>On stratification and optimum allocations</article-title>. <source>JASA</source>. <year>1951</year>;<volume>46</volume>:<fpage>95</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr18-0272989X11426176">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Punglia</surname><given-names>RS</given-names></name>
<name><surname>D’Amico</surname><given-names>AV</given-names></name>
<name><surname>Catalona</surname><given-names>WJ</given-names></name>
<name><surname>Roehl</surname><given-names>KA</given-names></name>
<name><surname>Kuntz</surname><given-names>KM</given-names></name>
</person-group>. <article-title>Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen</article-title>. <source>N Engl J Med</source>. <year>2003</year>;<volume>349</volume>:<fpage>335</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr19-0272989X11426176">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Irwig</surname><given-names>L</given-names></name>
<name><surname>Glasziou</surname><given-names>PP</given-names></name>
<name><surname>Berry</surname><given-names>G</given-names></name>
<name><surname>Chock</surname><given-names>C</given-names></name>
<name><surname>Mock</surname><given-names>P</given-names></name>
<name><surname>Simpson</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Efficient study designs to assess the accuracy of screening tests</article-title>. <source>Am J Epidemiol</source>. <year>1994</year>;<volume>140</volume>:<fpage>759</fpage>–<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr20-0272989X11426176">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>White</surname><given-names>RH</given-names></name>
<name><surname>Sadeghi</surname><given-names>B</given-names></name>
<name><surname>Tancredi</surname><given-names>DJ</given-names></name><etal/>
</person-group>. <article-title>How valid is the ICD-9-CM based AHRQ patient safety indicator for postoperative venous tromboembolism?</article-title> <source>Med Care</source>. <year>2009</year>;<volume>47</volume>:<fpage>1237</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr21-0272989X11426176">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McNamee</surname><given-names>R</given-names></name>
</person-group>. <article-title>Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value</article-title>. <source>Stat Med</source>. <year>2002</year>;<volume>21</volume>:<fpage>3609</fpage>–<lpage>25</lpage>.</citation>
</ref>
<ref id="bibr22-0272989X11426176">
<label>22.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Fleiss</surname><given-names>JL</given-names></name>
<name><surname>Levin</surname><given-names>B</given-names></name>
<name><surname>Paik</surname><given-names>MC</given-names></name>
</person-group>. <source>Statistical Methods for Rates Proportions</source>. <edition>3rd ed.</edition> <publisher-loc>New York</publisher-loc>: <publisher-name>Wiley-Interscience</publisher-name>; <year>2003</year>.</citation>
</ref>
<ref id="bibr23-0272989X11426176">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Begg</surname><given-names>CB</given-names></name>
<name><surname>Greenes</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Assessment of diagnostic tests when disease verification is subject to selection bias</article-title>. <source>Biometrics</source>. <year>1983</year>;<volume>39</volume>:<fpage>207</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr24-0272989X11426176">
<label>24.</label>
<citation citation-type="gov">
<collab>Agency for Healthcare Research and Quality</collab>. <article-title>PSI technical specifications</article-title>, <comment>Version 4.2</comment> (<month>September</month> <year>2010</year>). <article-title>Available from:</article-title> <comment><ext-link ext-link-type="uri" xlink:href="http://qualityindicators.ahrq.gov/TechnicalSpecs42.htm">http://qualityindicators.ahrq.gov/TechnicalSpecs42.htm</ext-link></comment></citation>
</ref>
<ref id="bibr25-0272989X11426176">
<label>25.</label>
<citation citation-type="gov">
<person-group person-group-type="author">
<name><surname>Quan</surname><given-names>H</given-names></name>
<name><surname>Drosler</surname><given-names>S</given-names></name>
<name><surname>Sundararajan</surname><given-names>V</given-names></name>
<etal/>
</person-group>; <collab>the IMECCHI Investigators</collab>. <article-title>Adaptation of AHRQ Patient Safety Indicators for Use in ICD-10 Administrative Data by an International Consortium</article-title>. <source>AHRQ Advances in Patient safety 2: News Directions and Alternatives Approaches. Vol 1. Assessment</source>. <publisher-name>Taxonomies and Measurement. Agency for Health Care Research and Quality Publication</publisher-name> <year>2008</year>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.ahrq.gov/downloads/pub/advances2/vol1/Advances-Quan_52.pdf">http://www.ahrq.gov/downloads/pub/advances2/vol1/Advances-Quan_52.pdf</ext-link></comment></citation>
</ref>
<ref id="bibr26-0272989X11426176">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhan</surname><given-names>C</given-names></name>
<name><surname>Miller</surname><given-names>MR</given-names></name>
</person-group>. <article-title>Administrative data based patient safety research: a critical review</article-title>. <source>Qual Saf Health Care</source>. <year>2003</year>;<volume>12</volume>(<issue>Suppl 2</issue>):<fpage>58</fpage>–<lpage>63</lpage>.</citation>
</ref>
<ref id="bibr27-0272989X11426176">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Angioli</surname><given-names>R</given-names></name>
<name><surname>Gómez-Marín</surname><given-names>O</given-names></name>
<name><surname>Cantuaria</surname><given-names>G</given-names></name>
<name><surname>O’Sullivan</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Severe perineal lacerations during vaginal delivery: the University of Miami experience</article-title>. <source>Am J Obstet Gynecol</source>. <year>2000</year>;<volume>182</volume>:<fpage>1083</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr28-0272989X11426176">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Attilakos</surname><given-names>G</given-names></name>
<name><surname>Sibanda</surname><given-names>T</given-names></name>
<name><surname>Winter</surname><given-names>C</given-names></name>
<name><surname>Johnson</surname><given-names>N</given-names></name>
<name><surname>Draycott</surname><given-names>T</given-names></name>
</person-group>. <article-title>A randomised controlled trial of a new handheld vacuum extraction device</article-title>. <source>Br J Obstet Gynaecol</source>. <year>2005</year>;<volume>112</volume>:<fpage>1510</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr29-0272989X11426176">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aukee</surname><given-names>P</given-names></name>
<name><surname>Sundström</surname><given-names>H</given-names></name>
<name><surname>Kairaluoma</surname><given-names>MV</given-names></name>
</person-group>. <article-title>The role of mediolateral episiotomy during labour: analysis of risk factors for obstetric anal sphincter tears</article-title>. <source>Acta Obstet Gynecol</source>. <year>2006</year>;<volume>85</volume>:<fpage>856</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr30-0272989X11426176">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lahmann</surname><given-names>NA</given-names></name>
<name><surname>Halfens</surname><given-names>RJ</given-names></name>
<name><surname>Dassen</surname><given-names>T</given-names></name>
</person-group>. <article-title>Prevalence of pressure ulcers in Germany</article-title>. <source>J Clin Nurs</source>. <year>2005</year>;<volume>14</volume>:<fpage>165</fpage>–<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr31-0272989X11426176">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barbut</surname><given-names>F</given-names></name>
<name><surname>Parzybut</surname><given-names>B</given-names></name>
<name><surname>Boelle</surname><given-names>PY</given-names></name>
<etal/>
</person-group>. <article-title>Pressure sores in a university hospital [in French]</article-title>. <source>Presse Med</source>. <year>2006</year>;<volume>35</volume>:<fpage>769</fpage>–<lpage>78</lpage>.</citation>
</ref>
<ref id="bibr32-0272989X11426176">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stausberg</surname><given-names>J</given-names></name>
<name><surname>Kroger</surname><given-names>K</given-names></name>
<name><surname>Maier</surname><given-names>I</given-names></name>
<name><surname>Niebel</surname><given-names>W</given-names></name>
<name><surname>Schneider</surname><given-names>H</given-names></name>
</person-group>. <article-title>Frequency of decubitus ulcer in patients of a university medical center: combination of routine documentation and cross-sectional study [in German]</article-title>. <source>Dtsch Med Wochenschr</source>. <year>2005</year>;<volume>130</volume>:<fpage>2311</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr33-0272989X11426176">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Berlowitz</surname><given-names>DR</given-names></name>
<name><surname>Brand</surname><given-names>HK</given-names></name>
<name><surname>Perkins</surname><given-names>C</given-names></name>
</person-group>. <article-title>Geriatric syndromes as outcome measures of hospital care: can administrative data be used?</article-title> <source>J Am Geriatr Soc</source>. <year>1999</year>;<volume>46</volume>:<fpage>692</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr34-0272989X11426176">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vanderwee</surname><given-names>K</given-names></name>
<name><surname>Clark</surname><given-names>M</given-names></name>
<name><surname>Dealey</surname><given-names>C</given-names></name>
<name><surname>Gunningberg</surname><given-names>L</given-names></name>
<name><surname>Defloor</surname><given-names>T</given-names></name>
</person-group>. <article-title>Pressure ulcer prevalence in Europe: a pilot study</article-title>. <source>J Eval Clin Pract</source>. <year>2007</year>;<volume>13</volume>:<fpage>227</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr35-0272989X11426176">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Drösler</surname><given-names>SE</given-names></name>
<name><surname>Cools</surname><given-names>A</given-names></name>
<name><surname>Köpfer</surname><given-names>T</given-names></name>
<name><surname>Stausberg</surname><given-names>J</given-names></name>
</person-group>. <article-title>Are quality indicators derived from routine data suitable for evaluating hospital performance? First results using the AHRQ patient safety indicators in Germany [in German]</article-title>. <source>Z Arztl Fortbild Qualitätssich</source>. <year>2007</year>;<volume>101</volume>:<fpage>35</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr36-0272989X11426176">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brubaker</surname><given-names>L</given-names></name>
<name><surname>Bradley</surname><given-names>CS</given-names></name>
<name><surname>Handa</surname><given-names>VL</given-names></name>
<etal/>
</person-group>. <article-title>Anal sphincter laceration at vaginal delivery: is this event coded accurately?</article-title> <source>Obstet Gynecol</source>. <year>2007</year>;<volume>109</volume>:<fpage>1141</fpage>–<lpage>5</lpage>.</citation>
</ref>
<ref id="bibr37-0272989X11426176">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lijmer</surname><given-names>JG</given-names></name>
<name><surname>Mol</surname><given-names>BW</given-names></name>
<name><surname>Heisterkamp</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Empirical evidence of design-related bias in studies of diagnostic tests</article-title>. <source>JAMA</source>. <year>1999</year>;<volume>282</volume>:<fpage>1061</fpage>–<lpage>6</lpage>.</citation>
</ref>
<ref id="bibr38-0272989X11426176">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brenner</surname><given-names>H</given-names></name>
<name><surname>Gefeller</surname><given-names>O</given-names></name>
</person-group>. <article-title>Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence</article-title>. <source>Stat Med</source>. <year>1997</year>;<volume>16</volume>:<fpage>981</fpage>–<lpage>91</lpage>.</citation>
</ref>
<ref id="bibr39-0272989X11426176">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leeflang</surname><given-names>MMG</given-names></name>
<name><surname>Bossuyt</surname><given-names>PMM</given-names></name>
<name><surname>Irwig</surname><given-names>L</given-names></name>
</person-group>. <article-title>Diagnostic test accuracy may vary with prevalence: implication for evidence-based diagnosis</article-title>. <source>J Clin Epidemiol</source>. <year>2009</year>;<volume>62</volume>:<fpage>5</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr40-0272989X11426176">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dalenius</surname><given-names>T</given-names></name>
<name><surname>Hodges</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Minimum variance stratification</article-title>. <source>JASA</source>. <year>1959</year>;<volume>54</volume>:<fpage>88</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr41-0272989X11426176">
<label>41.</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name><surname>Horgan</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Choosing the stratification boundaries: the elusive optima</article-title>. <source>Istanbul Univ J School Bus Admin</source>. <comment>stanbul Üniversitesi sletme Fakültesi Dergisi Istanbul University Journal of the School of Business Administration Cilt/Vol:39, Sayi/No:2, 2010, 195-204</comment> <comment>ISSN: 1303-1732–<ext-link ext-link-type="uri" xlink:href="http://www.ifdergisi.org">www.ifdergisi.org</ext-link> ©2010</comment> <volume>2010</volume>;<volume>39</volume>:<fpage>195</fpage>–<lpage>204</lpage>.</citation>
</ref>
<ref id="bibr42-0272989X11426176">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sukhatme</surname><given-names>BV</given-names></name>
<name><surname>Tang</surname><given-names>VKT</given-names></name>
</person-group>. <article-title>Allocation in stratified sampling subsequent to preliminary test of significance</article-title>. <source>JASA</source>. <year>1975</year>;<volume>70</volume>:<fpage>175</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr43-0272989X11426176">
<label>43.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Pepe</surname><given-names>MS</given-names></name>
</person-group>. <article-title>Incomplete data and imperfect reference tests</article-title>. In: <source>The Statistical Evaluation of Medical Tests for Classification and Prediction</source>. <publisher-loc>Oxford, UK</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2003</year>. p <fpage>168</fpage>–<lpage>213</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>